10.03.2022 • News

Cinven Purported Buyer of Bayer’s ESP Unit

Private equity investor Cinven is poised to acquire Bayer’s Environmental Science Professional (ESP) unit, Bloomberg has reported. The news agency’s sources said the buyer of the business put up for sale a year ago was expected to be announced in the early part of March this year.

Bayer was reportedly asking a price of around €2 billion for the activities with around €600 million in annual sales. Bloomberg said Cinven had beat out potential buyers CVC Capital Partners and Brookfield Asset Management, with several others having dropped out of the bidding process.

The environmental science unit, part of Bayer CropScience, makes and sells products for lawns and gardens, golf courses, forestry and parks under the brand names Ficam, Maxforce, Esplanade and K-Othrine. ESP also offers a digital pest management system.

With the divestment, which was to be led by Gilles Galliou, previously head of commercial operations for Bayer Vegetable Seeds Americas, Crop Science division, the Leverkusen-based group said in March 2021 it would be able to sharpen its focus on its core agricultural business and accelerate its strategy implementation.

The ESP business planned to move from Germany to Cary, North Carolina, USA, part of the state’s Research Triangle, in mid-2021.

Author: Dede Williams, Freelance Journalist

(c) Bayer
(c) Bayer

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read